Floatz logo

Prasterone

Vaginal Carcinoma

Ohio State University Comprehensive Cancer CenterPhase 2Active
CCC
52/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
37/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Vaginal Carcinoma cohort.

Asset / SponsorPhaseRating
Durvalumab
M.D. Anderson Cancer Center
Phase 2B
Ipilimumab
National Cancer Institute (NCI)
Phase 2CCC
Dna Plasmid-Encoding Interleukin-12/Hpv Dna Plasmids Therapeutic Vaccine Medi0457
M.D. Anderson Cancer Center
Phase 2CCC
Nivolumab
National Cancer Institute (NCI)
Phase 2CCC
Plasmid Encoded Il-12
M.D. Anderson Cancer Center
Phase 2CCC

View all 18 →

Same molecule, other indications

Prasterone is also rated in:

postmenopausal atrophic vaginitisDormant
BB
Indicative ·
66 / 100
View asset →
systemic lupus erythematosusDormant
BB
Indicative ·
66 / 100
View asset →
breast cancerDormant
B
Indicative ·
61 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →